Recent Posts
Aspen Pharmacare Financial Growth: Navigating H1 2026’s Transitional Financial Landscape
Aspen Pharmacare Financial Growth Powers Through Strategic Shifts
Aspen Pharmacare's financial growth shines in its H1 2026 results, driven by resilient Commercial Pharmaceuticals,
South Africa’s Push for Local Lenacapavir Production to Enhance HIV Prevention
South Africa has launched a bold bid to enable local lenacapavir production, targeting the twice-yearly injectable long-acting HIV prevention drug from ...
SAHPRA GMP Compliance: Addressing Allegations Against Adcock Ingram’s Clayville Facility
SAHPRA GMP compliance at Adcock Ingram's Clayville facility has been reaffirmed by the South African Health Products Regulatory Authority (SAHPRA) in its